Our Recommendations
New Publications
- Good practice statement on the use of variant-containing COVID-19 vaccines (2022)
- Vaccin contre le Covid-19 : une troisième dose est-elle nécessaire ? (2021)
- WHO’s Science in 5 Episode #53 - COVID-19: Booster Shots (2021)
- Interim statement on COVID-19 vaccine booster doses (2021)
- Beschluss der STIKO zur 19. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung (2022)
Filter
13
Featured
Recommendations
2
Language
Document type
Guidelines
8
Situation Updates
2
Studies & Reports
1
Videos
1
Fact sheets
1
Countries / Regions
Germany
1
United Kingdom
1
Argentina
1
Ecuador
1
Authors & Publishers
Publication Years
Category
COVID-19
3
Guidelines
2
Policies
1
Toolboxes
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-...
Ethnic disparities in COVID-19 persist, with increased rates of infection, severe disease, and death among people from minority ethnic groups. COVID-19 vaccination rates also remain lowest in these communities compared with white people in the UK. Among people older than 18 years, the proportion who...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
September 2021
7 August 2021
Additional dose of the primary vaccination against COVID-19: Technical Guidelines
September 2021
Guidelines for the Vaccination Scheme against
COVID 19: Booster Dose Health Personnel
